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Background: Community-based programs are being widely adopted in the struggle to prevent cardiovascular
diseases. No study has been conducted in Japan to evaluate the effects of a community-based health promotion
program by using the Framingham risk score and 10-year CHD risk as outcome variables. The aim of the present
study was to assess the effects of a program involving 6-month intervention and 18-month follow-up using such
outcomes.
Methods: Participants (n = 1,983, 39.5% women, mean age 63.4 years) were selected for the study in 2008. Of these
1,983, 347 (42.4% women) subjects received the 6-month intervention. The intervention included individual
counseling and group sessions, among others. After 18 months, 1,278 participants (intervention group: 238, control
group: 1,040) were followed up. Changes in the Framingham risk score and 10-year coronary heart disease (CHD)
risk were evaluated. ANCOVA and multiple logistic models adjusted for baseline value, age, sex and intervention
times were used.
Results: The results showed that the differences in the Framingham risk score and mean 10-year CHD risk were
significant in the intervention group compared with the control group after 6-month follow-up (−0.46 and −1.12,
respectively) and were also significant after 18-month follow-up (−0.39 and −0.85, respectively). The proportion of
those with intermediate 10-year CHD risk (> = 10%) was significantly lower at 6 months (OR 0.30, 95% CI 0.12-0.74)
and at 18 months (OR 0.41, 95% CI 0.19-0.92).
Conclusions: The six-month intervention program effectively decreased estimated 10-year CHD risk and the effects
were still present at 18-month follow-up.
Trial registration: UMIN-CTR: UMIN000008163
Keywords: Coronary disease, Lifestyle, Prevention, Risk factors* Correspondence: yasuo-h@dokkyomed.ac.jp
1Department of Public Health, Dokkyo Medical University School of Medicine,
Tochigi, Japan
Full list of author information is available at the end of the article
© 2013 Zhu et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Zhu et al. BMC Public Health 2013, 13:219 Page 2 of 10
http://www.biomedcentral.com/1471-2458/13/219Background
Morbidity and mortality due to cardiovascular dis-
ease are now the leading public health problems in
industrialized countries, including Japan [1,2]. Heart
disease is the second leading cause of mortality in
Japan [2].
Community-based programs are being widely adopted
in the struggle to prevent cardiovascular diseases. Com-
munity approaches to cardiovascular disease (CVD)
prevention are attractive, since they can target all
groups in the community and, if effective, may
achieve widespread behavioral change and risk reduction.
A number of community CVD prevention programs have
been implemented over the last 40 years [3].
As the incidence of cardiovascular disease is largely
explained by modifiable risk factors (serum choles-
terol and reduced high-density-lipoprotein cholesterol,
blood pressure and cigarette smoking), reducing risk
factors through health promotion focusing on lifestyle
is a logical way of preventing disease [4].
In the meantime, as evidence-based health promo-
tion is becoming more and more important, out-
come evaluation variables are needed by experts to
evaluate the effect of health promotion programs.
Since it is not appropriate to trace the incidence of
cardiovascular disease for an intervention study, esti-
mation equations to evaluate the incidence rate have
been widely adopted. The Framingham risk score
used to evaluate 10-year coronary heart disease
(CHD) risk is the most popular estimation equation,
which was derived from the Framingham Heart
Study [5-8]. Many intervention studies implemented
in Western countries have used the Framingham risk
score to evaluate the effect of intervention studies
[9-15].
In Asia, although there has been some controversy
over whether the Framingham risk score overesti-
mates the risk of CHD in Asian populations [16,17],
it is still used by experts to provide useful informa-
tion on future CHD events [18,19].
To our knowledge, this study is the first to use the
Framingham risk score and 10-year CHD risk to
evaluate the effects of a community-based health
promotion program in Japan.
The hypothesis in this study was that, similar to
studies conducted in Western countries, lifestyle in-
terventions could reduce the Framingham risk score
and estimated 10-year CHD risk after 18-month
follow-up relative to a control group.
The aim of the present study was to assess the ef-
fect of a program involving six-month intervention
and 18-month follow-up in a Japanese community
using Framingham risk score and 10-year CHD risk
as outcome variables.Methods
Study design
The Ministry of Health, Labour and Welfare (MHLW)
in Japan started the “Specific Health Check-up Project”
nationally in 2008. This study was one part of the pro-
ject, which was implemented in Soka City in Saitama
Prefecture, Japan, with a population of about 233,000
[20,21].
The present study employed a non-randomized con-
trolled trial design. The program was provided from
2008 to 2010, including a 6-month intervention program
and an 18-month follow-up program.Participants
About 50,000 residents aged from 40–74 were invited to
receive a health check-up. As shown in Figure 1, 12,961
residents aged 40–75 years old underwent health check-
ups in 2008 and completed the baseline lifestyle ques-
tionnaire. Of these 12,961 subjects, 1,983 were selected
for the study according to the following inclusion cri-
teria [22], which were separated into two steps: (1) waist
circumferences of the subjects as follows: ①waist cir-
cumference > =85 cm for males,> = 90 cm for females;
②waist circumference < 85 cm for males, <90 cm for fe-
males, and body mass index (BMI) > =25 kg/m2; (2) at
least one of the following: hemoglobin (HbA1c) >5.2%
(JDS, Japan Diabetes Society) (equal to >5.6% [NGSP,
National Glycohemoglobin Standardization Program])
[23] or taking diabetes medication; triglycerides (TG)
>150 mg/dl or high-density-lipoprotein cholesterol
(HDL-C) <40 mg/dl or taking lipid-lowering medication;
systolic blood pressure (SBP) > =130 mmHg or diastolic
blood pressure (DBP) > =85 mmHg or taking hyperten-
sion medication; and having a history of smoking. The
subjects who were taking diabetes, lipid-lowering and
hypertension medication and were diagnosed as hyper-
tension (SBP/DBP > = 140/90 mmHg), hyperlipidemia
(LDL > =140 mg/dl or HDL <40 mg/dl or TG > =
150 mg/dl), diabetes (Fasting blood glucose > = 126 mg/
dl or HbA1c > = 6.1% (JDS) (equal to > =6.5% [NGSP]))
were advised to be seen by physicians, and were with-
drawn from this study. The 1,983 subjects were in-
formed about the program by direct mail and were then
allocated into either the intervention or the control
group according to the participants’ desire. The numbers
of subjects in the intervention and control groups were
347(200 males and 147 females) and 1,636 (999 males
and 637 females), respectively. After 6-month follow-up,
1,288 (251 in the intervention group and 1,037 in the
control group) participants underwent the second health
check-up and completed the lifestyle questionnaire. Fi-
nally, after the 18-month follow-up, 1,278 participants
(238 in the intervention group and 1,040 in the control
Figure 1 Flowchart of the study protocol.
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questionnaire in 2010 (Figure 1).Risk factor measurements
All of the measurements were provided by medical
institutions. Body weight and height were measured with
no shoes and excess clothing removed on the same cali-
brated scale at the baseline, 6-month and 18-month
follow-up. BMI was calculated as body weight (kg) di-
vided by the square of the height (m2). Waist circumfer-
ence was measured by nurses. SBP and DBP were
measured using auto-manometers (Omron Co., Tokyo,
Japan). Fasting blood samples from all subjects were
obtained and TG, low-density lipoprotein cholesterol
(LDL-C), HDL-C and HbA1c were measured at a labora-
tory (Saitama, Japan).Subjects with overweight were defined as having a
BMI > =25 kg/m2; subjects with hypertension risk were
defined as having at least one of the following: SBP > =
130 mmHg or DBP > =85 mmHg; subjects with dys-
lipidemia risk were defined as having at least one of
the following: HDL-C <40 mg/dl, LDL-C > =140 mg/dl
or TG > =150 mg/dl; subjects with diabetes risk were
defined as having a HbA1c > 5.2% (JDS) (equal to >5.6%
[NGSP]).
We used the Framingham risk score, which is based
on age, TC, HDL-C, SBP and current smoking status, in
order to establish risk scores [8]. HDL-C was classified
into 4 levels (> = 60, 50–59, 40–49, <40 mg/dl). SBP was
classified into 5 levels (<120,120-129,130-139,140-159,> =
160 mmHg). TC was calculated according to the
Friedewald equation [24]. Estimated 10-year CHD risk
was evaluated according to the Framingham risk score
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risk with a definition of > =10% [8].
Assessment of lifestyle variables
Information on lifestyle factors such as smoking,
drinking alcohol, dietary behaviors and physical ac-
tivity, medical history and sleeping was obtained by
a self-administered questionnaire at the baseline, 6
and 18 months.
Current smokers were defined as those who had been
smoking for 6 months or had smoked over 100 ciga-
rettes and were still smoking in the previous month.
Drinking alcohol was indicated by the frequency of
drinking and the amount of alcohol consumption per
day. Dietary behaviors included eating speed, usual time
for eating supper, eating snacks and skipping breakfast.
Physical activity included regular exercise, daily physical
activity and walking speed. Sleeping status was catego-
rized as well or not well.
In this study, the preferable lifestyle behaviors were de-
fined as follows: no smoking, exercise over 30 minutes
and 2 times per week, walking or having physical activity
over 1 hour every day, walking faster than their peers,
not eating fast, not eating dinner less than 2 hours be-
fore sleeping, not eating snacks over 3 times every week,
not skipping breakfast over 3 times every week, not
drinking alcohol every day, drinking alcohol less than
22 g and sleeping well.
Intervention
All subjects in the intervention and control groups were
given 3 health checkups and 3 lifestyle surveys at the
baseline, 6-month follow-up, and 18-month follow-up.
The common program consisted of a lecture regarding
the purpose of health promotion at the baseline and
newsletters featuring general health information pro-
vided by local community health workers during the 18-
month period.
For the intervention group, a comprehensive program
consisting of a 6-month intervention was provided. The
6-month intervention program included individual
counseling and group sessions, in addition to the com-
mon program.
Individual counseling
Individual counseling was conducted on the basis of the
results of health check-ups and health assessment charts
on lifestyle at the baseline (60 minutes per person).
Group sessions
The group sessions focused on nutrition and exercise
(a total of 12 times of 60–120 minutes duration). The
nutrition group sessions included talks, a lecture, coo-
king demonstrations and motivational interviewing. Theexercise group sessions included aerobic exercises, stret-
ching, walking and other exercises in a gym or local
health or community center. The same program was
provided during the daytime and at night for the con-
venience of participants. Through these approaches, par-
ticipants were encouraged to set their own goals for
lifestyle modification.Other interventions by telephone and letter
The other interventions included contact by telephone
(a total of 3 times of 5–15 minutes duration) and letter
(a total of 3 times). Through telephone calls and letters,
subjects were advised to attend the group sessions and
motivated to change their lifestyle behaviors. Those who
were absent from the group sessions were also followed
up by telephone or letter to inquire about the reason.
The changes in lifestyle behaviors among the subjects
were also evaluated by questions over the telephone.Statistical analysis
We selected lifestyle behaviors and cardiovascular
disease risks as outcome measures in this study.
Lifestyle behaviors included smoking, dietary behav-
iors, physical activity, drinking alcohol and sleeping.
Cardiovascular disease risks included weight, BMI,
waist circumference, SBP, DBP, HDL-C, LDL-C, TG
and HbA1c.
Baseline cardiovascular disease risk and lifestyle
behavior differences were analyzed by Student’s t-test
for continuous variables, Mann–Whitney test for non-
parametric variables and Chi-squared test for catego-
rical variables.
The mean differences in changes in cardiovascular
disease risk factors at 6 and 18 months between the
intervention and control groups were assessed by covari-
ance analysis adjusted for the baseline value, age, sex
and intervention times. Comparisons of lifestyle behav-
iors at 6 and 18 months between the intervention and
control groups were conducted by multiple logistic
regression analysis adjusted for the baseline category,
age and sex. The odds ratios (OR) and 95% confidence
interval (95% CI) were used to indicate the relative risk
ratio between the intervention and control groups. In
addition, we determined the probability of risk in sub-
jects with overweight, hypertension risk, dyslipidemia
risk, diabetes risk, metabolic syndrome and 10-year
CHD risk by multiple logistic regression analysis ad-
justed for the baseline category, age, sex and interven-
tion times. All statistical analyses were performed using
an assumed type I error rate of 0.05. Statistical analyses
were performed using SPSS Statistics 20.0 for Windows
(SPSS Japan Inc., Tokyo, Japan).
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Results
Baseline characteristics of participants
The baseline characteristics of the study participants are
presented in Table 1. The mean age in the intervention
group was significantly higher than that in the control
group (P < 0.001). In addition, the baseline characteris-
tics of the completed and drop-out subjects in the inter-
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Exercise over than 30 min, > = 2 times/week
Walking or physical activity over than 1 hour every day
Walking faster than their peers
Dietary behavior
Eating fast
Eating dinner less than 2 hours before sleeping
Eating snacks over than 3 times every week
Skipping breakfast over than 3 times every week
Drinking alcohol every day
Drinking alcohol less than 22 g
Sleeping well
BMI = body mass index, waist = waist circumference, SBP = systolic blood pressure, D
LDL-C = low-density lipoprotein cholesterol, TG = Triglycerides, HbA1c = Hemoglobin
aby chi-squared or Student’s t-test.
bby Mann–Whitney test.2009, the mean age in the drop-out group was younger
than that in the completed group (P = 0.006). In 2010,
weight and mean 10-year CHD risk were higher and
HDL-C was lower in the drop-out group than in the
completed group (P = 0.012, 0.018 and 0.011 respect-
ively). Other variables including the Framingham risk
score showed no significant differences between the two
groups.
The proportions of those with current smoking
(P = 0.023), eating dinner late (P = 0.009) and skipping
breakfast (P < 0.001) were significantly lower in the
intervention group than those in the control group. Thes and lifestyle behaviors between intervention and
ention N = 347 Control N = 1,636 P-valuea
ean ± S.D. Mean ± S.D.
65.0 ± 7.8 63.0 ± 8.8 <0.001
66.1 ± 8.1 66.8 ± 9.2 0.166
25.8 ± 2.3 25.8 ± 2.4 0.960
91.0 ± 5.8 90.9 ± 6.2 0.942
34.0 ± 14.6 135.5 ± 16.6 0.121
79.7 ± 9.7 80.8 ± 10.5 0.077
7.3 ± 14.5 56.2 ± 14.9 0.179
34.0 ± 29.6 133.8 ± 32.1 0.933
51.1 ± 95.8 165.8 ± 130.7 0.287b
.34 ± 0.47 5.38 ± 0.82 0.395
14.0 ± 2.5 13.7 ± 2.9 0.085
9.3 ± 6.0 9.4 ± 6.4 0.646
N (%) N (%)
200 (57.6) 999 (61.1) 0.236
147 (42.4) 637 (38.9)
62 (17.9) 384 (23.5) 0.023
159 (51.6) 595 (39.7) <0.001
168 (54.9) 707 (47.3) 0.015
171 (55.9) 771 (52.1) 0.231
88 (28.5) 410 (27.4) 0.686
62 (20.1) 406 (27.2) 0.009
42 (13.6) 200 (13.4) 0.900
22 (7.1) 218 (14.6) <0.001
156 (50.5) 669 (44.7) 0.063
143 (60.9) 666 (56.8) 0.249
247 (81.0) 1148 (77.2) 0.147
BP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol,
, CHD = coronary heart disease.
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and daily physical activity (P = 0.015) were significantly
higher in the intervention group than those in the con-
trol group. There were no other significant differences
in baseline characteristics between the two groups.
The number of interventions in the intervention group
was an average of 7.1 (range from1 to15) (not show
in Table).
Changes in lifestyle behaviors
Table 2 shows the odds ratios of preferable lifestyle be-
haviors in the intervention group versus the control
group. Multiple logistic regression analysis adjusted for
each baseline category, age and sex showed that the pro-
portion of those performing regular exercise was signifi-
cantly higher in the intervention group than in the
control group at 6 months (OR 1.79, 95% CI 1.24-2.59).
The proportion of those who walked or did physical ac-
tivity over 1 hour every day was significantly higher in
the intervention group than in the control group at 6 -
months (OR 1.51, 95% CI 1.06-2.14). The proportion of
those who walked faster than their peers was signifi-
cantly higher in the intervention group than in the con-
trol group at 6 months (OR 1.45, 95% CI 1.01-2.09). The
proportion of those who ate snacks over than 3 times
every week was significantly lower in the intervention
group than in the control group at 6 months (OR 0.35,
95% CI 0.17-0.71) and it was still lower at 18 months
(OR 0.48, 95% CI 0.23-0.98). There were no other
significant differences in lifestyle behaviors between the
two groups. Moreover, in 2009, 37 people (6 in the inter-
vention group and 31 in the control group) stopped
smoking after 6-month follow-up, which accounted for





Exercise over 30 min, > = 2 times/week 1.79
Walking or physical activity over than 1 hour every day 1.51
Walking faster than their peers 1.45
Dietary behavior
Eating fast 1.45
Eating dinner less than 2 hours before sleeping 0.82
Eating snacks over than 3 times every week 0.35
Skipping breakfast over than 3 times every week 0.45
Drinking alcohol every day 0.78
Drinking alcohol less than 22 g 1.57
Sleeping well 1.01
aby multiple logistic regression analysis adjusted for baseline category, age and sexand 49 in the control group) stopped smoking after 18-
month follow-up, which accounted for 4.5%.
Changes in cardiovascular disease risks
Baseline to 6-month changes in cardiovascular disease
risks between the two groups are displayed in Table 3.
Presented below and in the tables are the unadjusted
means and adjusted P values by using covariance
analysis controlling for age, sex, baseline values and
intervention times.
The mean decreases in weight (P = 0.002) and BMI
(P = 0.004) in the intervention group showed significant
differences compared with those in the control group.
The average Framingham risk score in the intervention
group showed a significant decrease (P = 0.002). The
mean 10-year CHD risk also showed a significant de-
crease in the intervention group (P = 0.001).
HDL-C and LDL-C in the intervention group showed
slight increases compared with those in the control
group, but the increases were not statistically significant.
All other cardiovascular disease risks showed a decrease
in the intervention group, but the reductions were not
statistically significant.
The changes in cardiovascular disease risks between
the two groups at 18 months are shown in Table 4.
Covariance analysis adjusted for baseline values, age, sex
and intervention times showed that the average weight
(P = 0.003), BMI (P = 0.007), waist circumference (P = 0.039)
and TG (P = 0.021) in the intervention group were
significantly decreased at 18 months. The Framingham
risk score (P = 0.022) and mean 10-year CHD risk
(P = 0.027) were significantly decreased in the interven-
tion group compared with those in the control group.
DBP, HDL-C and LDL-C in the intervention groupintervention and control groups














Table 3 Comparison of changes in cardiovascular disease risk between intervention and control groups at 6-month
follow-up
N
Baseline 6-month Intervention vs. Control
Mean ± S.D. Mean ± S.D. Difference P-valuea
Weight, kg
Intervention 251 65.6 ± 8.0 63.7 ± 8.2 −0.93 0.002
Control 1037 65.7 ± 8.3 65.2 ± 8.6
BMI, kg/m2
Intervention 251 25.8 ± 2.2 25.1 ± 2.3 −0.37 0.004
Control 1037 25.6 ± 2.2 25.4 ± 2.4
Waist, cm
Intervention 250 90.9 ± 5.9 88.5 ± 6.6 −0.77 0.129
Control 1036 90.3 ± 5.6 89.6 ± 6.3
SBP, mmHg
Intervention 251 133.7 ± 14.0 130.8 ± 13.0 −1.77 0.212
Control 1037 134.8 ± 15.5 133.0 ± 15.0
DBP, mmHg
Intervention 251 80.0 ± 9.4 77.4 ± 8.7 −1.54 0.092
Control 1036 80.4 ± 10.3 79.3 ± 9.7
HDL-C, mg/dl
Intervention 251 57.9 ± 15.2 58.5 ± 15.1 0.91 0.267
Control 1037 56.8 ± 15.1 56.6 ± 15.3
LDL-C, mg/dl
Intervention 250 134.7 ± 30.1 130. ± 30.3 2.78 0.227
Control 1036 131.9 ± 30.9 129.4 ± 29.7
TG, mg/dl
Intervention 251 141.1 ± 65.8 130.8 ± 71.0 −14.9 0.150
Control 1036 158.8 ± 125.9 148.2 ± 114.3
HbA1c,%
Intervention 251 5.33 ± 0.43 5.25 ± 0.38 −0.05 0.179
Control 1033 5.33 ± 0.62 5.33 ± 0.57
Framingham risk score, score
Intervention 250 14.0 ± 2.4 13.9 ± 2.4 −0.46 0.002
Control 1029 13.9 ± 2.7 13.9 ± 2.9
Mean 10-year CHD risk, %
Intervention 250 9.1 ± 5.9 8.9 ± 6.0 −1.12 0.001
Control 1030 9.4 ± 6.2 9.6 ± 6.5
BMI = body mass index, waist = waist circumference, SBP = systolic blood pressure, DBP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol,
LDL-C = low-density lipoprotein cholesterol, TG = Triglycerides, HbA1c = Hemoglobin, CHD = coronary heart disease.
aby covariance analysis adjusted for baseline values, age, sex and intervention times.
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control group, but the increases were not statistically
significant. All other cardiovascular disease risks
showed a decrease in the intervention group, but the re-
ductions were not statistically significant.
Table 5 shows the odds ratios of cardiovascular disease
risks in the intervention group versus the control group.
Multiple logistic regression analysis adjusted for each
baseline category, age, sex and intervention times showed
that the proportion of those with intermediate 10-year
CHD risk (> = 10%) was significantly lower in the inter-
vention group than in the control group at 6 months (OR
0.30, 95% CI 0.12-0.74) and at 18 months (OR 0.41, 95%
CI 0.19-0.92). The proportion of those with dyslipidemia
risk was significantly lower in the intervention group
than in the control group at 18 months (OR 0.59, 95%
CI 0.36-0.97).
Discussion
The major finding of the present study is a significant
decrease in the mean 10-year CHD risk at 6-monthfollow-up and that the effects were still sustained at
18-month follow-up. The number of subjects with
intermediate 10-year CHD risk (> = 10%) also de-
creased significantly at each follow-up time.
A previous study also showed significant change in
10-year CHD risk after lifestyle intervention. The re-
sults from the PREMIER Trial showed that, in indi-
viduals with prehypertension or stage 1 hypertension,
2 multicomponent behavioral interventions (EST +
DASH and EST) significantly reduced the estimated
10-year CHD risk by 12% and 14%, respectively [9].
The DEPLOY pilot study indicated that community-
based delivery of the DPP lifestyle intervention could
have a significant effect on prevention of CHD in
overweight adults with abnormal glucose metabolism.
At 4 and 12 months, the intervention group experi-
enced significant decreases in 10-year risk from
baseline (−3.28%, P < 0.001; and −2.23%, P = 0.037)
compared with control subjects (−0.78%, P = 0.339;
and +1.88%, P = 0.073) [14]. The California WISE-
WOMAN Project reported that the improvement in
Table 4 Comparison of changes in cardiovascular disease risk between intervention and control groups at 18-month
follow-up
N
Baseline 18-month Intervention vs. Control
Mean ± S.D. Mean ± S.D. Difference P-valuea
Weight, kg Intervention 238 65.4 ± 7.9 63.8 ± 8.2 −1.08 0.003
Control 1040 66.0 ± 8.7 65.4 ± 9.2
BMI, kg/m2 Intervention 238 25.7 ± 2.2 25.1 ± 2.3 −0.38 0.007
Control 1040 25.7 ± 2.3 25.5 ± 2.6
Waist, cm Intervention 238 90.8 ± 5.7 88.9 ± 6.5 −1.13 0.039
Control 1040 90.6 ± 5.9 90.0 ± 6.7
SBP, mmHg Intervention 238 133.9 ± 14.5 131.2 ± 14.0 −0.91 0.520
Control 1040 135.2 ± 16.1 132.4 ± 14.8
DBP, mmHg Intervention 238 79.6 ± 9.6 78.1 ± 9.0 0.27 0.778
Control 1040 80.7 ± 10.5 78.4 ± 9.9
HDL-C, mg/dl Intervention 238 58.6 ± 15.0 58.6 ± 14.8 1.10 0.214
Control 1040 56.6 ± 15.1 56.3 ± 15.3
LDL-C, mg/dl Intervention 238 134.2 ± 29.1 127.0 ± 27.9 0.59 0.823
Control 1040 133.9 ± 31.5 127.5 ± 31.7
TG, mg/dl Intervention 238 143.6 ± 74.2 136.5 ± 76.2 −25.1 0.021
Control 1040 163.4 ± 131.1 156.7 ± 119.4
HbA1c,% Intervention 238 5.32 ± 0.39 5.31 ± 0.39 −0.03 0.429
Control 1040 5.35 ± 0.66 5.38 ± 0.57
Framingham risk score, score Intervention 238 13.9 ± 2.4 14.0 ± 2.5 −0.39 0.022
Control 1040 13.9 ± 2.7 14.1 ± 2.9
Mean 10-year CHD risk,% Intervention 238 8.7 ± 5.8 8.8 ± 5.9 −0.85 0.027
Control 1040 9.3 ± 6.4 9.8 ± 6.6
BMI = body mass index, waist = waist circumference, SBP = systolic blood pressure, DBP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol,
LDL-C = low-density lipoprotein cholesterol, TG = Triglycerides, HbA1c = Hemoglobin, CHD = coronary heart disease.
aby covariance analysis adjusted for baseline values, age, sex and intervention times.
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intervention group (EIG) than for a usual care group
(UCG), and this improvement was significantly grea-
ter when the women’s CHD risk levels were in the
upper quartile at baseline [15].
From the results of our study, other cardiovascular
disease risk factors did not show significant results,
except for weight and BMI. This may have been
caused by the 10-year CHD risk reflecting theTable 5 Odds ratios of cardiovascular risks in intervention ve






Intermediate 10-year CHD risk (> = 10%) 0.30
CHD = coronary heart disease.
aby multiple logistic regression analysis adjusted for baseline category, age, sex andcomprehensive effect of intervention. Maybe some of
the cardiovascular disease risk factors changed a
little, but this was still not significant. When we
combined the changes in cardiovascular disease risk
factors together into the 10-year CHD risk, it
showed a significant change.
The present study also showed the sustainment of the
effect when the intervention was stopped after 18-
month follow-up. This proved that the effect of a short-rsus control group at each risk with baseline
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follow-up period, greater than one year.
Similar results were also shown in other previous stud-
ies. Lindstrom et al. found that lifestyle intervention in
people at high risk for type 2 diabetes resulted in
sustained lifestyle changes, a modest difference in body
weight change and reduction in diabetes incidence,
which remained after the individual lifestyle counseling
stopped [25]. A study conducted by Elmer et al. showed
that, over 18 months, persons with prehypertension and
stage 1 hypertension could sustain multiple lifestyle
modifications that improve control of blood pressure
and could reduce the risk for chronic disease [26]. Four-
year results of the Look AHEAD Trial indicated that in-
tensive lifestyle intervention can produce sustained
weight loss and improvements in other CVD risk factors
in individuals with type 2 diabetes [27].
The results of the present study indicated significant
decrease in weight and body mass index at 6-month
follow-up. In addition, the reductions were sustained
and showed significantly stronger decrease at 18-month
follow-up. This proved that, by implementing lifestyle
intervention, weight loss can be achieved, which is simi-
lar to the results of previous studies.
In a lifestyle intervention study implemented among
persons at high risk for cardiovascular disease and dia-
betes in a rural community, 52% of participants met the
7% weight loss goal and 66% achieved at least a 5%
weight loss [28]. However, the sample size was very
small (N = 84 and N = 65, respectively). A study con-
ducted by Lindstrom et al. in 2003 indicated that, after 1
and 3 years, weight reductions were 4.5 and 3.5 kg in
the intervention group and 1.0 and 0.9 kg in the control
group, respectively [29]. In the present study, weight re-
duction was 1.5 kg in the intervention group and 0.6 kg
in the control group after 18 months.
The present study has limitations. Firstly, our study
has a non-randomized study design. The participants
were allocated to either the intervention or the control
group on the basis of each participant’s desire. The
subjects with a strong desire to improve their lifestyle
were more inclined to accept the intervention and then
acquired a better effect of changes in cardiovascular
disease risk and lifestyle behavior. However, since the
baseline cardiovascular disease risk factors were similar
in the two groups, the non-randomized study design
may not affect the main significant results in the
changes of cardiovascular disease risk in our study.
Secondly, the assessment of lifestyle behavior change
in the study was based on a self-reported questionnaire.
This may have resulted in some recall bias when evaluat-
ing the change in lifestyle behavior and have led to little
significant change in lifestyle behavior between the inter-
vention and control groups. Further study should focuson a detailed method to evaluate the change in lifestyle
behavior, such as using pedometers to measure change
in physical activity.
Thirdly, this study has a high drop-out rate. On the
one hand, as the results showed, younger people were
more inclined to withdraw from our study, maybe
because they were not interested in the form of the
intervention. For example, younger people may prefer to
choose more vigorous exercises instead of the jogging
and gymnastics done in our study. On the other hand,
subjects with higher BMI, thus having higher 10-year
CHD risk, were more inclined to withdraw from our
study, which limited the significance of the results.
Lastly, the number of participants was relatively
small, especially in the intervention group, which
might have limited the significance of the results and
the generalization to the middle-aged Japanese popu-
lation. Regarding the generalization of this study, the
intensity of intervention that targeted a large percent-
age of the population who are at high risk of CVD
may have been too strong. In a future study, a new
method of intervention of less intensity should be de-
veloped, which can be applied worldwide, considering
the limited ability of health services in many areas.
Conclusions
Our study demonstrates that the six-month intervention
program effectively improved the cardiovascular disease
risk and estimated 10-year CHD risk. Moreover, the
effects were still present at the 18-month follow-up.
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